Literature DB >> 16176284

Vascular endothelial growth factor 121 is the predominant isoform in psoriatic scales.

Yan Zhang1, Hiroaki Matsuo, Eishin Morita.   

Abstract

Vascular endothelial growth factor (VEGF) is a powerful agent that causes hyperpermeability of blood vessels as well as endothelial cell proliferation. Recent investigations have revealed that production of VEGF increases in epidermis of psoriatic lesions, and the overproduced VEGF plays an important role in the pathogenesis of psoriasis. In this study, we used immunohistochemical staining as well as extraction of stratum corneum with physiological saline to further analyse VEGF produced in psoriatic lesions. Biological activity of VEGF in the psoriatic scales was assayed by cultured human umbilical vein endothelial cells in vitro. The immunohistochemical examination confirmed an increased production of VEGF in the keratinocytes of psoriatic lesions. In addition, we found that the content of VEGF contained in the psoriatic scales was approximately 50 times greater than that in normal stratum corneum. We also found that VEGF 121 isoform, which has an exclusive ability to cause hyperpermeability of blood vessels, was predominantly detected in psoriatic scales, suggesting a major role of VEGF 121 isoform on the altered structure of microvessels in psoriatic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176284     DOI: 10.1111/j.1600-0625.2005.00356.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

Review 2.  [Early antiexudative response--OCT monitoring after intravitreal bevacizumab injection].

Authors:  M Völcker; S Peters; W Inhoffen; F Ziemssen
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

3.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

4.  Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.

Authors:  Shahrzad Asadi; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Alexandra Miniati; Nikolaos Sismanopoulos; Magdalini Vasiadi; Bodi Zhang; Dimitrios Kalogeromitros; Theoharis C Theoharides
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

5.  Genetic Risk Factors for Psoriasis in Turkish Population: -1540 C/A, -1512 Ins18, and +405 C/G Polymorphisms within the Vascular Endothelial Growth Factor Gene.

Authors:  Tuba Bozduman; Sibel Ersoy Evans; Sevilay Karahan; Yildiz Hayran; Filiz Akbiyik; Incilay Lay
Journal:  Ann Dermatol       Date:  2016-01-28       Impact factor: 1.444

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.